Allele‐specific silencing therapy for Dynamin 2‐related dominant centronuclear myopathy-Reference-Cited by-同舟云学术

Allele‐specific silencing therapy for Dynamin 2‐related dominant centronuclear myopathy

Published:2017-12-15 Issue:2 Volume:10 Page:239-253
ISSN:1757-4676
Container-title:EMBO Molecular Medicine
language:en
Short-container-title:EMBO Mol Med

Author:

Trochet Delphine¹^ORCID,Prudhon Bernard¹,Beuvin Maud¹,Peccate Cécile¹,Lorain Stéphanie¹,Julien Laura¹,Benkhelifa‐Ziyyat Sofia¹,Rabai Aymen²,Mamchaoui Kamel¹,Ferry Arnaud¹,Laporte Jocelyn²,Guicheney Pascale³^ORCID,Vassilopoulos Stéphane¹,Bitoun Marc¹^ORCID

Affiliation:

1. Research Center for Myology UPMC Univ Paris 06 and INSERM UMRS 974 Institute of Myology Sorbonne Universités Paris France

2. Department of Translational Medicine and Neurogenetics IGBMC, INSERM U964, CNRS UMR7104 Collège de France University of Strasbourg Illkirch France

3. Institute of Cardiometabolism and Nutrition (ICAN) INSERM UMR_S1166 UPMC Univ Paris 06 Sorbonne Universités Paris France

Funder

Institut National de la Santé et de la Recherche Médicale

Université Pierre et Marie Curie

Centre National de la Recherche Scientifique

Agence Nationale de la Recherche

Publisher

EMBO

Subject